UV-induced DNA damage and mutations in hupki (human p53 knock-in) mice recapitulate p53 hotspot alterations in sun-exposed human skin

Cancer Research

Volumn 61, Issue 22, 2001, Pages 8158-8163

  Luo, Jun Li ^a   Hergenhahn, Manfred ^a   Koomagi, Riita ^a   Yang, Qin ^a   Hollstein, Monica ^a   Tong, Wei Min ^b   Galendo, Dominique ^b   Wang, Zhao Qi ^b   Yoon, Jung Hoon ^c   Pfeifer, Gerd P ^c  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^c CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ANIMAL TISSUE; ARTICLE; DNA BINDING; DNA DAMAGE; DNA REPAIR; GENE MUTATION; GROWTH REGULATION; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; KERATINOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; SUN EXPOSURE; TANDEM REPEAT; TISSUE SPECIFICITY; TUMOR GROWTH; TUMOR LOCALIZATION; TUMOR SUPPRESSOR GENE; ULTRAVIOLET RADIATION;

AMINO ACID SEQUENCE; ANIMALS; CHROMOSOME MAPPING; DNA DAMAGE; GENES, P53; HUMANS; MICE; MOLECULAR SEQUENCE DATA; MUTATION; PROTEIN STRUCTURE, TERTIARY; PYRIMIDINE DIMERS; RECOMBINANT FUSION PROTEINS; SKIN; SKIN NEOPLASMS; SUNLIGHT; ULTRAVIOLET RAYS;

EID: 20244375365     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Surfing the p53 network
2. P53 mutations in human cancers
3. P53 and human cancer: The first ten thousand mutations
4. The yeast p53 functional assay: A new tool for molecular epidemiology. Hopes and facts
5. New approaches to understanding p53 gene tumor mutation spectra
6. Knock-in mice with a chimeric human/murine p53 gene develop normally and show wild-type p53 responses to DNA damaging agents: A new biomedical research tool
7. Sunlight and the onset of skin cancer
8. Frequent clones of p53-mutated keratinocytes in normal human skin
9. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma
10. Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers
11. Sunburn and p53 in the onset of skin cancer
12. The distribution of UV photoproducts along the human p53 gene and its relation to mutations in skin cancer
13. Sunlight induces pyrimidine dimers preferentially at 5-methylcytosine bases
14. Unusual profile and high prevalence of p53 mutations in esophageal squamous cell carcinomas from Northern Iran
15. Early p53 alterations in mouse skin carcinogenesis by UVB radiation: Immunohistochemical detection of mutant p53 protein in clusters of preneoplastic epidermal cells
16. Involvement of 5-methylcytosine in sunlight-induced mutagenesis
17. Analysis of the gene coding for the murine cellular tumour antigen p53
18. The role of UV-B light in skin carcinogenesis through the analysis of p53 mutations in squamous cell carcinomas of hairless mice
19. 1-induced mouse lung tumors
20. Chronic inflammation, mutation, and cancer
21. Oxidative stress and cell cycle checkpoint function
22. Increased p53 mutation load in nontumorous human liver of Wilson disease and hemochromatosis: Oxyradical overload diseases
23. Ultraviolet B radiation-induced skin cancer in mice defective in the Xpc, Trp53, and Apex (HAP1) genes: Genotype-specific effects on cancer predisposition and pathology of tumors
24. Association between INK4a-ARF and p53 mutations in skin carcinomas of xeroderma pigmentosum patients
25. Ser-249 p53 mutations in plasma DNA from hepatocellular carcinoma patients from Gambia, West Africa
26. Benzo[a]pyrene-induced murine skin tumors exhibit frequent and characteristic G to T mutations in the p53 gene
27. Mechanisms of switching on p53: A role for covalent modification?
28. Pharmacological rescue of mutant p53 conformation and function
29. Reactivation of mutant p53 through interaction of a C-terminal peptide with the core domain
30. Genetic selection of intragenic suppressor mutations that reverse the effect of common p53 cancer mutations
31. Mechanism of rescue of common p53 cancer mutations by second-site suppressor mutations
32. A common polymorphism acts as an intragenic modifier of mutant p53 behaviour